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ABSTRACT
We developed two new site-specific recombination
systems named VCre/VloxP and SCre/SloxP for
genome engineering. Their recognition sites are dif-
ferent from Cre recognition sites because VCre and
SCre recombinases share less protein similarity
with Cre, even though the basic 13-8-13 structures
of their recognition sites are identical. Mutant VloxP
and SloxP, which have the same uses as mutant
loxP, were also developed. VCre/VloxP and SCre/
SloxP in combination with Cre/loxP and Flp/FRT
systems can serve as powerful tools for genome
engineering, especially when used to genetically
modify both alleles of a single gene in mouse and
human cells.
INTRODUCTION
Two popular tools used in genomic engineering are the
Cre/loxP and Flp/FRT site-speciﬁc recombination
systems (1), which are often used to develop conditional
knockout mice. Cre/loxP is typically used for knocking
out exon(s) in genes of interest, whereas Flp/FRT is
used for removing neo cassettes of positive selection
markers so that normal gene expression remains intact.
Cre recombinase originates from P1 phage and recognizes
the loxP site, which is composed of an 8-bp sequence
ﬂanked on either side by two 13-bp inverted repeats,
forming a 13-8-13 structure. Cre recombinase can excise
a region of DNA surrounded by two loxP sites. On the
other hand, Flp recombinase originates from yeast
plasmid 2m and recognizes distinct FRT sites, which
have the same 13-8-13-bp structure as loxP sites. The re-
combination efﬁciency of the Flp/FRT system, however, is
less than that of the Cre/loxP system (2). To improve re-
combination efﬁciency, some have attempted to optimize
Flp through mutations, resulting in the conversion of Flp
to a thermostable FLP mutant (2) and adaptation for
codon usage (3). Many mutant recognition sites for loxP
[e.g. lox2272 (4), lox551, lox66 and lox71 (5)] andFRT [e.g.
F3 and F5 (6)] have been developed, along with various
methods for excising DNA sequences, exchanging cassettes
[i.e. recombinase-mediated cassette exchange (RMCE) (7)],
and inverting DNA sequences in a genome. Other valuable
methods and applications also have been developed, such
as conditional gene trap (8) and viral vector packaging (9)
using native and mutant recognition sites of these two
site-speciﬁc recombination systems.
Despite of the usefulness of alternative site-speciﬁc re-
combination systems, which when used in combination
with other methods can serve as valuable tools, still only
a few unconventional systems (10–13) are available for
genome engineering. Although Dre recombinase from
phage D6 recognizes a 32-bp DNA site (rox), to our
knowledge, mutant rox sites are yet to be developed.
The site-speciﬁc integrase from bacteriophage phiC31
catalyzes unidirectional recombination between its 39-bp
attP and 34-bp attB recognition sites. Because phiC31
integrase recognizes 100–1000 sites (called pseudo attP
or attB sites) in human and mouse genomes that possess
partial sequence identity to attP or attB, phiC31 integrase
is unﬁt for genome engineering of speciﬁc alleles (14).
Alternative combinations of recombination systems with
various types of mutant recognition sites, in addition to
the Cre/loxP and Flp/FRT systems, can be powerful tools
for genetically modifying genomes, allowing researchers to
perform ﬁne genomic manipulations and to construct
more complex systems. Additional recombination tools
would especially beneﬁt human-induced pluripotent stem
(iPS) cell applications necessitating the genetic modiﬁca-
tion of both alleles of a gene. In mice, both alleles of
a gene are knocked out by mating heterozygote mice
with single-allele knockout mice. In humans, however,
this strategy is not practical. Just as various restriction
enzymes recognizing different sites are valuable bio-
technology tools, so too would various site-speciﬁc recom-
bination systems serve as valuable genome
engineering tools. For this reason, we sought to identify
recombinases that recognize different sites.
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In silico prediction of two new site-speciﬁc recombinases—
VCre and SCre—and their VloxP and SloxP sites
We searched for potential Cre homologs by performing a
BLAST search of the public DNA database Genbank/
EMBL/DDBJ. The GenBank/EMBL/DDBJ accession
numbers of two Cre orthologues, VCre and SCre
proteins, are ABX77110 and ABK50591, respectively,
and those of the plasmids containing VCre and SCre are
CP000756 (15) and CP000470, respectively.
To identify putative site-speciﬁc recombination sites for
VCre and SCre, we used criteria that would increase the
probability that the candidates are indeed true site-speciﬁc
recombination sites. These criteria are as follows.
(i) Palindromic structure. The candidate site-speciﬁc re-
combination site should have a palindromic struc-
ture. The 13-8-13-bp structure of loxP (for Cre) and
FRT (for Flp) is palindromic. Thus, the site-speciﬁc
recombination site of Cre homologs also should be
palindromic. At this time, however, we were not
concerned about recognition-site sequence similar-
ity, size of inverted repeat (13bp), and perfect
matching of the inverted repeat.
(ii) Proximity of the Cre homolog to its recognition site
within the plasmid. The site-speciﬁc recombination
site should be located near the Cre homolog gene
and should be contained within the same plasmid,
because the loxP site is located near the Cre gene in
the P1 phage genome. We speculated that during
evolution dynamic insertion and deletion events
may have occurred often in the plasmid. Thus, if
the recombinase and its recognition site were dis-
tantly located, they would be easily dispersed, ren-
dering each to become non-functional.
(iii) Not located in the ORF. The site-speciﬁc recombin-
ation site should not be located in the
protein-coding region. We speculated that the re-
combinase and its site-speciﬁc recognition site
co-evolved interactively. During evolution, it is
unlikely that the prototype site-speciﬁc recognition
site would have ‘jumped’ into the protein-coding
region without destroying protein function.
Candidate recognition sites were conﬁrmed via the experi-
ment described below.
We searched for sequences that were identical or highly
similar to those of VloxP and SloxP sites in mouse and
human genomes by performing a BLAST search using the
speciﬁed expectation value (E=1000) and by performing
a FASTA search of the Genbank/EMBL/DDBJ database
using VloxP and SloxP as query sequences.
Construction of plasmid expressing VCre tagged with
NLS and FLAG
The plasmid pTurboCre was a kind gift from Dr Jon
Kratochvil (Washington University, St Louis, MO,
USA). pTurboCre constitutively produces Cre recombin-
ase from a CMV enhancer upstream from a chicken
b-actin promoter, which drives the untranslated region
of the ﬁrst exon, ﬁrst intron and part of the second exon
of the b-actin gene, as described previously (16). Nuclear
localization signal (NLS)-FLAG-VCre and NLS-
FLAG-SCre was composed of a SV40 NLS and a
FLAG sequence introduced into the N terminus of the
VCre ORF or SCre ORF, respectively. The artiﬁcially
synthesized genes were optimized for mouse codon usage
in addition to removing all CpG dinucleotides (Genscript
Inc). pTurboVCre and pTurboSCre were constructed by
replacing the NLS-Cre gene with NLS-FLAG-VCre or
NLS-FLAG-SCre, respectively.
We constructed tester plasmids by inserting two of each
recognition site ﬂanked by a stop cassette (blasticidin re-
sistance) in front of the EGFP gene of pEGFP-C3
(Clontech). The following oligomers were used for the
PCR ampliﬁcation of the blasticidin resistance cassette
(which contains a bacterial promoter, stop codon and
poly-A addition signals) of pcDNA6TR (Invitrogen,):
primer-01, primer-02 for VloxP; primer-03, primer-04 for
VloxM1; primer-05, primer-06 for VloxM2; primer-07,
primer-08 for loxP. All primers are listed online in the
Supplementary Data.
To construct tester plasmids pVloxP-EGFP,
pVloxM1-EGFP, pVloxM2-EGFP and ploxP-EGFP, we
digested the resulting PCR products with NheI and AgeI,
and the resulting fragments were ligated into the NheI and
AgeI site of pEGFP-C3 (Clontech).
The following oligomers were used to construct tester
plasmids pVloxBsd-loxPCm and pVloxBsd-Vlox2272Cm
and for the PCR ampliﬁcation of the chloramphenicol
(Cm) resistance gene of pBACe3.6 (Invitrogen):
primer-09, primer-10 for loxP; primer-11, primer-12 for
Vlox2272. The resulting PCR products were digested
with BamHI and XhoI, and the resulting fragments were
ligated into the BamHI and XhoI sites of pVloxP-EGFP.
All constructs were conﬁrmed by DNA sequencing.
The following oligomers were used to construct tester
plasmids pSloxP-EGFP, pSloxBsd-loxPCm and
pSloxBsd-Slox2272Cm and for PCR ampliﬁcation:
primer-13, primer-14 for SloxP; primer-15, primer-16 for
Slox2272.
Recovery of plasmid DNA from transfected cells
Using FuGENE 6 (Roche), we co-transfected Flp-in
TREx 293 cells (Invitrogen) with a tester plasmid
(pVloxP-EGFP, pVloxM1-EGFP, pVloxM2-EGFP or
ploxP-EGFP) and pTurboVCre, which encodes VCre re-
combinase. Twenty-four hours after transiently transfect-
ing the cells, the cells were dissolved with DNA-extraction
buffer [100 mM Tris–HCl (pH 8.5), 5mM EDTA,
200mM NaCl, 0.2% SDS] containing 100mg/ml protein-
ase K, and the DNA from the transfected cells was
puriﬁed by means of isopropanol precipitation.
Assessing site-speciﬁc recombination activity through
transient transfection of VCre or SCre expression
plasmids
Flp-in TREx 293 cells (Invitrogen), which originate from
HEK293 cells, were plated at a density of 2 10
5 cells per
dish with appropriate DMEM medium on poly-D-
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Corporation). The expression plasmids encoding VCre,
Cre or SCre and tester plasmids were transfected into
HEK293 cells using FuGENE 6 Transfection Reagent
(Roche). Twenty-four hours after transfection, cells were
washed with PBS, ﬁxed with 4% paraformaldehyde in
0.1M phosphate buffer and 3.4% sucrose for 30min at
room temperature. Transfected cells were observed with
an Olympus IX71 ﬂuorescence microscope.
Construction of temperature-sensitive plasmids expressing
VCre, SCre or Cre under temperature control in
Escherichia coli
Plasmid pSIM18 (a kind gift provided by Dr Donald L.
Court, National Cancer Institute-Frederick, Fredrick,
MD, USA) is a temperature-sensitive, low-copy plasmid
(pSC101) that carries an expression system under the
control of the   pL promoter and the cI857 temperature-
sensitive repressor (17). Plasmid pSIM18 carries the
hygromycin-resistant gene.
Dre gene was synthesized artiﬁcially using the original
codon-usage pattern of Enterobacteria phage D6
(Genscript Inc.). We constructed expression plasmids by
inserting VCre, SCre, Cre and Dre genes under the control
of the pL promoter of pSIM18. The following oligomers
were used for the PCR ampliﬁcation of the backbone of
pSIM18: primer-17, primer-18.
The following oligomers were used to construct
plasmids pSIMVCre, pSIMSCre, pSIMCre and
pSIMDre and for the PCR ampliﬁcation of the VCre,
SCre, Cre and Dre genes: primer-19, primer-20 for
VCre; primer-21, primer-22 for SCre; primer-23,
primer-24 for Cre; primer-25, primer-26 for Dre.
To construct expression plasmids pSIMVCre,
pSIMSCre, pSIMCre and pSIMDre, we digested the re-
sulting PCR products with AscI and NotI, and the result-
ing fragments were ligated into the AscI and NotI site of
the PCR product of the backbone of pSIM18. In plasmids
pVloxPAmp-loxPCm, pSloxM1Amp-loxPCm and
pRoxAmp-loxPCm, we replaced the appropriate recogni-
tion site and antibiotics resistance gene using
pVloxPBsd-loxPCm. We used the 32-bp rox site, which
is recognized by Dre recombinase, and a segment with a
two-base innate boundary in D6 phage, (A)TAACTTTA
AATAAT TGGC ATTATTTAAAGTTA(G).
Assessing site-speciﬁc recombination activity through
VCre or SCre expression plasmids in E. coli
Escherichia coli DH10B-bearing expression plasmids
pSIMVCre, pSIMSCre, pSIMCre and pSIMDre, which
encode VCre, SCre, Cre or Dre, respectively, were
grown in LB medium containing 75mg/ml hygromycin
overnight at 32 C under constant shaking. Fifty micro-
liters of the overnight culture was inoculated into 2ml of
fresh LB medium containing 75mg/ml hygromycin. The
culture was shaken for 2h at 32 C, and then transferred
into a 42 C water bath for 15min. For electroporation,
cells were washed three times with cold water and cold
10% glycerol, and then electroporated with tester
plasmid (0.2mg) in 25ml of 10% glycerol. Transformants
were incubated for 2h at 37 C, and then plated onto LB
agar plates containing 50mg/ml kanamycin (Km). One
hundred randomly selected colonies were replicated on
LB agar plates containing 100mg/ml ampicillin (Amp),
50mg/ml Km or 12.5mg/ml Cm to test growth activity.
The experiments were performed in triplicate. HaloTag
was fused to the recombinase in each expression system,
labeled with HaloTag-TMR ligand and then scanned with
a Fluorescence Image Analyzer. Quantitative analyses
revealed no differences in the expression level of any of
the recombinases after protein expression in E. coli was
induced by shifting temperature (data not shown).
Double Red recombination method for constructing Lin28
targeting vector
The Lin28-targeting vector used in the RMCE method
was constructed by using a high-throughput method
involving the   Red recombination system. We previously
constructed a BAC library containing  40000 clones
derived from the chromosomal DNA of R1 ES cells har-
vested from the F1 offspring of 129X1/SvJ and 129S1/Sv
mice (18). A BAC clone containing Lin28 was screened
from this library for targeting one 129 mouse allele. We
constructed the targeting vector by carrying out Red re-
combination two times. First, the DNA cassette for the
retrieving vector was produced by PCR ampliﬁcation
using the following primers and pDT-6 plasmid contain-
ing the diphtheria toxin A (DT-A) chain as templates:
primer-27, primer-28. The ﬁrst Red recombination was
performed in order to construct pDTLin28 plasmid from
a BAC clone (No. 68A24) containing Lin28 gene using the
DNA cassette for retrieving.
Second, the tag cassette was produced by serial PCR
ampliﬁcation using the following primers and pDTLin28
and pBSloxPEGFPtkNeo plasmids as templates:
primer-29, primer-30. To integrate the EGFP-tag
cassette into the C terminus of the Lin28-coding
sequence, we performed a second Red recombination.
The C terminus of Lin28 was fused to the EGFP gene in
frame. To increase the efﬁciency of cassette exchange, we
designed the tag cassette to contain loxP and lox2272 sites,
which were to be exchanged by using the RMCE method;
a neomycin resistance gene for positive selection; and the
herpes thymidine kinase gene for negative selection.
The tag-exchanging cassette for DsRed-contained loxP
and lox2272 sites, and a DsRed Monomer gene from
pDsRedMonomer (Clontech).
First homologous recombination
The linearized knock-in vector was introduced into mouse
ES cells (M1 originated from hybrid embryos derived
from C57BL/6 and 129Sv mice) by electroporation
(GenePulser; Bio-Rad). The ES cells were grown on
feeder cells in a medium containing 150mg/ml G418.
Each colony was picked up and expanded, and the
genomic DNA of each clone was puriﬁed. To identify
true homologous recombinant colonies, we analyzed
both outer sides of the knock-in vector through PCR amp-
liﬁcation and the following oligomers: primer-31,
primer-32 for 50-side testing; primer-33, primer-34 for
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homologous recombined colonies.
RMCE method
We designed another Cre gene optimized for mouse codon
usage; the gene lacked CpG dinucleotides. The artiﬁcial
sequence was synthesized by Genscript, Inc.
pTurboCreopti was constructed by replacing the
NLS-Cre gene with an NLS-tagged Creopti gene.
For RMCE, one of the knockin ES cell clones was
transfected with 25mg of pBSloxPDsRedMPuro2272 and
25mg of pTurboCreopti by electroporation (Genepulser;
Bio-Rad). The transfected ES cells were grown on feeder
cells in medium for ES cells containing 1mg/ml puro-
mycin. One day after incubation, the medium was
replaced with fresh medium containing 1mg/ml puromycin
and 2mM of ganciclovir for negative selection. Each ES
cell colony was picked up and expanded. The genomic
DNA of the ES cells was puriﬁed. For typing the
genomic DNA for the tag cassette in the ES cell
genome, we used the following oligomers for PCR ampli-
ﬁcation: primer-35, primer-36. The PCR products were
conﬁrmed by determining the size of the PCR products
by electrophoresis and by DNA sequencing. Typically,
 70% of the tested clones were engineered colonies
showing site-speciﬁc recombination via RMCE.
Second homologous recombination
For the modiﬁcation of the second allele (which originated
from a C57BL/6 mouse), we used a BAC clone (RP23-
281F6) containing mouse genomic DNA originating
from C57BL/6 mice (Invitrogen). We expected to
increase the possibility of targeting a different Lin28
allele by using genomic DNA from C57B6 mice, because
the ES cells we used originated from hybrid mice with a
C57B6 and 129Sv genetic background and because these
two alleles can be distinguished by certain
single-nucleotide polymorphisms (SNPs). Thus, we con-
structed a targeting vector containing VloxP sites for the
second allele by carrying out Red recombination two
times. First, the DNA cassette for the retrieving vector
was produced by PCR ampliﬁcation using the following
primers and pDT-6 plasmid as templates: primer-37 and
primer-28 for Lin28-site-D. The ﬁrst Red recombination
was performed to construct the pDTLin28-2nd-allele
plasmid. Second, the tag cassette was produced by serial
PCR ampliﬁcation using the following primers and
pDTLin28-2nd-allele and pENTR-puroBsd plasmid as
templates: primer-38, primer-39, primer-40, primer-41,
primer-42, primer-43, primer-44.
The linearized targeting vector, pDTLin28V-Puro was
introduced into mouse knock-in ES cells (clone No. 80,
Lin28 knockin ES cells) by electroporation (GenePulser;
Bio-Rad). The cells were grown in medium containing
1mg/ml puromycin. Each colony was picked up and
expanded, and the genomic DNA of each clone was
puriﬁed. The two outer sides of the knock-in vector were
examined by PCR ampliﬁcation (primer-45, primer-46 for
50-side testing; primer-47, primer-48 for 30-side testing),
and true homologous recombinant colonies were
detected. To conﬁrm modiﬁcation of both alleles of the
Lin28 gene, we performed Southern hybridization using
each outside probe.
VCre-dependent knockout of Lin28 gene via the VCre/
VloxP system
To remove exon 3 of Lin28 in one allele, we transfected ES
cells with 25mg of pTurboVCre by electroporation. The
ES cells were grown on feeder cells in standard medium.
Each colony was picked up and expanded, and the
genomic DNA of each clone was puriﬁed. PCR ampliﬁca-
tion was performed to identify ES cell colonies lacking
exon 3. PCR ampliﬁcation (primer-49 and primer-50)
and direct sequencing were carried out to conﬁrm
site-speciﬁc recombination.
These clones were also examined by Southern hybrid-
ization using outside probes. Typically,  80% of the
tested clones were engineered colonies showing site-
speciﬁc recombination.
Fluorescence microscopy analysis
ES cells were plated onto mitomycin C-treated MEF
feeder cells on glass bottom dishes (MatTek
Corporation). The cells were washed with PBS, ﬁxed
with 4% paraformaldehyde in 0.1M phosphate buffer
and 3.4% sucrose for 30min at room temperature. Cells
were examined for expression of EGFP- or DsRed-fusion
proteins with an Olympus IX71 ﬂuorescence microscope
equipped with UPlanApo 40 /0.85 objectives.
Observations were recorded with a Hamamatsu
ORCA-ER CCD camera.
Southern-blot analysis
Southern-blot analysis was performed with two
DIG-labeled DNA probes located outside the targeting
vector. Southern-blot analyses of each ES cell clone were
performed using two probes. Each probe was generated by
PCR ampliﬁcation of genomic DNA containing the Lin28
gene with the following oligomers: primer-51 and
primer-52 for the 50 probe of 516bp; primer-53 and
primer-54 for the 30 probe of 537bp.
Immunoblotting
ES cells were grown under standard growth conditions.
Cell extracts were prepared by washing the cells with
PBS and adding 100ml of lysis buffer [10 mM Tris–HCl
(pH 7.5), 150mM NaCl, 1mM EDTA, 1% Nonidet P-40]
containing Complete Protease Inhibitor (Roche). After a
30-min incubation on ice, lysates were centrifuged at
15000rpm for 10min in a microcentrifuge. Immunoblot
analysis was performed according to a procedure
described previously (19). Brieﬂy, aliquots of extract
were analyzed by immunoblotting using anti-Lin28
antibody [Lin28(A177); Cell Signaling Technology,
Danvers, MA, USA]. The bands were detected using the
ECLplus western-blotting detection system (Amersham
Biosciences) according to the manufacturer’s instructions
and visualized with a Luminescent Image Analyzer
LAS4000 mini (Fujiﬁlm).
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VCre speciﬁcally recombines the VloxP site
We searched for candidate site-speciﬁc recombinases that
recognize different sites by performing a BLAST search of
the Genbank/EMBL/DDBJ database using the Cre amino
acid sequence as a query sequence. The search returned
one possible candidate, which we named VCre. VCre
showed very weak similarity to Cre, sharing 29%
identity to the Cre amino acid sequence (Supplementary
Figure S1). We chose to focus our analysis on VCre
because we expected that it would recognize a distinct
site due to its low-sequence homology to Cre and
because it originates from plasmid p0908 of Vibrio sp.
(Supplementary Figure S1). The replication of plasmid
p0908 of Vibrio sp. is analogous to that of P1 phage,
which replicates as a circular plasmid in the lysogenic
state within a bacterial cell. From the 81-kbp sequence
of p0908 plasmid, we predicted a VCre recognition
sequence, VloxP, which has a 13-8-13-bp structure
(Figure 1A). However unlike loxP, VloxP has one
mismatch present in its 13-bp inverted repeats.
To demonstrate that VCre can catalyze a recombination
reaction at VloxP sites, we synthesized VCre gene using a
DNA sequence optimized for mouse codon usage and
removed all CpG sequences, which can convey potential
gene-silencing effects. To enhance recombination efﬁ-
ciency, we fused the SV40 NLS to the N terminus of
VCre (1). The expression plasmid (pTurboVCre, which
expresses VCre) was driven by the strong constitutive
CAG promoter. We created a tester plasmid by ﬂanking
a blasticidin resistance gene containing a stop codon and
poly-A addition signals with two VloxP sites; this cassette
was located between a CMV promoter and EGFP gene
(Figure 1B). To conﬁrm the site-speciﬁc recombination of
VCre, we co-transfected HEK293 cells with an expression
plasmid expressing VCre recombinase and with the tester
plasmid described above. DNA was puriﬁed from the
co-transfected cells, and then electroporated into E. coli
to recover the tester plasmid. The tester plasmid recovered
from co-transfected cells was  1 kbp shorter than the
original tester plasmid from cells not transfected with
the expression plasmid (Figure 1C). DNA sequencing of
the shortened plasmid conﬁrmed that the 787-bp segment
containing the blasticidin resistance cassette ﬂanked by
two VloxP sites was eliminated by VCre recombinase.
The tester plasmid lacking VCre could not produce
EGFP (Figure 1D, panel a), because the CMV promoter
and EGFP gene was separated by the blasticidin resistance
cassette containing a stop codon and poly-A addition
signals ﬂanked by two VloxP sites. When the cassette con-
taining the stop codon and poly-A addition signals was
removed by site-speciﬁc recombination, EGFP was
produced from the shortened tester plasmid. Indeed, bril-
liant EGFP signals were observed in cells expressing VCre
protein (Figure 1D, panel b).
Unlike loxP, VloxP has one mismatch present in its
13-bp inverted repeat. Thus, we wondered whether this
mismatch signiﬁcantly decreases recombination efﬁciency.
To address this issue, we created a perfect 13-bp inverted
repeat for VloxP by constructing two mutants, VloxM1
and VloxM2 (Figure 1A). Cells were co-transfected with
each tester plasmid series (pVloxP-EGFP, pVloxM1-
EGFP or pVloxM2-EGFP), which contained either
VloxP or mutant pVlox sites, and an expression plasmid
that either expressed or lacked VCre recombinase. DNA
from the co-transfected cells was puriﬁed, and site-speciﬁc
recombination was determined by PCR analysis using
primers F and R, as illustrated in Figure 1B. All of the
original tester plasmids produced 1012-bp PCR products,
whereas the tester plasmid recombined via VloxP
produced a shorter 225-bp PCR product. Figure 1E
shows the site-speciﬁc recombination of the VCre and
VloxP series in HEK293 cells expressing both VCre re-
combinase and a tester plasmid (pVloxP-EGFP,
pVloxM1-EGFP or pVloxM2-EGFP). The 787-bp
segment containing the blasticidin resistance cassette
ﬂanked by either VloxP or mutant sites was eliminated
by VCre recombinase. The present assay showed no sig-
niﬁcant difference in the recombination efﬁciency of
VloxP, VloxM1 and VloxM2.
VCre/VloxP and Cre/loxP systems can be used together
within the same cell because VCre/VloxP and Cre/loxP
do not cross-react
Next, we checked the cross-reactivity between Cre and
VCre. VloxP differs from loxP by 16 bases, which trans-
lates to 53% homology. Only 7 bases of the 13-bp inverted
repeat of VloxP are identical to the 13-bp inverted repeat
of loxP. Of course, no similarity was found between VloxP
and FRT. As shown in Figure 1E, VCre did not react with
the loxP site and Cre did not react with the VloxP,
VloxM1 and VloxM2 sites because the shorter 225-bp
PCR product was not detected. In contrast, Cre reacted
with the loxP site because the shorter 225-bp PCR product
was detected.
To conﬁrm that there is no cross-reactivity between
VCre/VloxP and Cre/loxP systems, even when VloxP
and loxP sites are located very close to each other, we
constructed a tester plasmid containing two VloxP and
two loxP sites (Figure 1F) and co-transfected it into
HEK293 cells with either an expression plasmid-lacking
recombinase or with plasmids expressing VCre or Cre re-
combinase. We then performed PCR analyses using
primers F and R (Figure 1F) to detect site-speciﬁc recom-
bination. When the tester plasmid was introduced into
cells lacking recombinase, we detected a 3557-bp PCR
product. Its large size indicates that none of its compo-
nents were deleted by site-speciﬁc recombination. In
contrast, when a plasmid expressing VCre recombinase
was co-introduced into the cells, we detected a shorter
2770-bp PCR product (Figure 1G, lane 2), which is con-
sistent with the size of a product lacking the blasticidin
resistance cassette ﬂanked by two VloxP sites. Other short
PCR products were not detected. These results strongly
demonstrate that VCre recombinase recombines only
VloxP sites but not loxP sites, even when VloxP and
loxP sites are located proximally within the same
plasmid. When cells were co-transfected with a tester
plasmid and expression plasmid expressing Cre recombin-
ase, we detected a short 2448-bp PCR product (Figure 1G,
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lacking the Cm resistance cassette ﬂanked by two loxP
sites. Again, no other short PCR products were
detected. These results strongly show that Cre recombin-
ase recombines only loxP sites but not VloxP sites, even
when VloxP and loxP sites are located proximally within
the same plasmid. This experiment, which used a tester
plasmid containing two VloxP and two loxP sites, con-
ﬁrmed that the recognition sites are not interchangeable
and that no cross-reactivity exists between VCre and Cre
recombinase.
VloxP and Vlox2272 do not cross-react even though
VCre recombines both sites
We examined the mutant sites of the VCre/VloxP system,
because mutant loxP sites can serve as very useful tools for
genome engineering, signiﬁcantly increasing the utility of
the Cre/loxP system. Previous analysis of loxP mutants
demonstrated that the 8-bp core sequence directs the
orientation and convertibility of mutant loxP sites (1).
Two base substitutions in the 8-bp sequence of VloxP
were made to form mutant Vlox2272, which possesses a
C-to-G substitution at position no. 2 and an A-to-T
Figure 1. VCre/VloxP and SCre/SloxP site-speciﬁc recombination systems. (A) Comparison of loxP, VloxP and SloxP sites with three mutant sites
(lox2272, Vlox2272 and Slox2272) and various other mutant sites. (B) Schematic diagram of expression and tester plasmids. (C) Recovery of the
tester plasmid from cells expressing VCre protein. Both expression and tester plasmids shown in (B) were simultaneously transfected into cells. The
size of the original tester plasmid and the plasmid eliminated via VloxP were 5545 and 4758bp, respectively. M, size markers ( /HindIII; 23, 9.4, 6.6,
4.4, 2.3 and 2.0kb). (D) EGFP expression was induced by removing a stop codon and poly-A cassette via VCre/VloxP. The VCre-expressing plasmid
and tester plasmid shown in (B) were transfected into HEK293 cells. Scale bar, 10mm. (E) Site-speciﬁc recombination using VCre and Cre. Either the
VCre- or Cre-expressing plasmid and a tester plasmid harboring loxP, VloxP or mutant VloxP sites were introduced into cells. The arrow indicates
the PCR product with the DNA ﬂanked by loxP, VloxP, VloxM1 and VloxM2 eliminated. (F) Schematic diagram of a tester plasmid containing two
VloxP sites and two loxP sites. (G) The mutant Vlox2272 site functions as an inconvertible mutant site. The tester plasmids shown in (F) and the
VCre- or Cre-expressing plasmids were transfected into cells. The open arrow indicates the PCR product containing DNA ﬂanked by VloxP and
Vlox2272. Reaction with only VloxP or loxP(Vlox2272) produced 2770- or 2448-bp PCR products, respectively. The solid arrow indicates the PCR
product in which both of the two DNA regions ﬂanked by VloxP and Vlox2272 were eliminated. (H) Recovery of tester plasmid from cells expressing
SCre protein. The tester plasmids, pSloxP-EGFP and SCre-expressing plasmid and pTurboSCre were simultaneously transfected into cells. The sizes
of the tester plasmid containing SloxP and the tester plasmid without SloxP were 5545 and 4758bp, respectively. (I) Site-speciﬁc recombination using
SCre, VCre and Cre. The tester plasmids (pSloxP-EGFP, ploxP-EGFP or pVloxP-EGFP) and SCre-, Cre- or VCre-expressing plasmids were
transfected into cells in various combinations. The arrow indicates the PCR product in which DNA ﬂanked by SloxP was eliminated in a
SCre-dependent manner. (J) Schematic diagram of a tester plasmid containing two SloxP sites and Slox2272 sites. (K) The mutant Slox2272 site
functions as an inconvertible mutant site. The tester plasmid shown in (J) and the SCre-expressing plasmid were transfected into cells. The open
arrow indicates the PCR product without the eliminated DNA. Reaction with only SloxP or Slox2272 produced 2770- or 2448-bp PCR products,
respectively. The solid arrow indicates the PCR product in which both of the two DNA regions ﬂanked by SloxP and Slox2272 were eliminated.
(L) Recovery of the tester plasmid containing two SloxP sites and Slox2272 sites from cells expressing SCre protein. The tester plasmid (pSloxPBsd–
Slox2272Cm) and the SCre-expressing plasmid (pTurboSCre) were simultaneously transfected into cells. The sizes of the original tester plasmid and the
eliminated plasmid were 6648 and 4752bp, respectively. Lanes 2–4 contain the plasmids of independent colonies recovered from cells expressing SCre.
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Vlox2272 because its base substitutions were analogous
to those of lox2272 and because two other substitutions
in the 8-bp sequence of Vlox2272 matched that of lox2272
(Figure 1A).
To conﬁrm that VloxP and Vlox2272 do not cross-react,
we constructed a tester plasmid containing two VloxP and
two Vlox2272 sites (Figure 1F) and co-transfected it into
HEK293 cells along with a plasmid-lacking recombinase
or plasmids expressing either VCre or Cre recombinase.
We then performed PCR analyses using primers F and R
(Figure 1F) to detect site-speciﬁc recombination. When
the tester plasmid was introduced into cells lacking recom-
binase, we detected a 3557-bp PCR product. Its large size
indicates that none of its components were removed by
site-speciﬁc recombination. In contrast, when a tester
plasmid expressing VCre recombinase was co-introduced,
we detected a shorter 1661-bp PCR product (Figure 1G,
lane 5), which is consistent with the size of a product
lacking both the blasticidin resistance cassette ﬂanked by
two VloxP sites and the Cm resistance cassette ﬂanked by
two Vlox2272 sites. In addition, two other minor PCR
products, 2270 and 2448bp, were detected. The 2270-bp
PCR product corresponded to a segment that lacked the
blasticidin resistance cassette ﬂanked by two VloxP sites,
whereas the 2448-bp PCR product corresponded to a
segment that lacked the Cm resistance cassette ﬂanked
by two Vlox2272 sites. The 2270- and 2448-bp PCR
products resulted from the reaction of only one VloxP
site or only one Vlox2272 site, respectively, and are
thought to be intermediate products of the reaction
producing the ﬁnal 1661-bp product, i.e. reaction of the
two VloxP sites and two Vlox2272 sites. Since our assay
did not detect any other shortened PCR products, we
concluded that VCre reacted with the two Vlox2272 sites
but did not react to the combination VloxP/Vlox2272 sites
(Figure 1G). When the tester plasmid containing two
VloxP and two Vlox2272 sites was transfected into cells
containing the expression plasmid expressing Cre recom-
binase, no shortened PCR product was detected
(Figure 1G, lane 6), indicating that Cre recombinase
does not react with either VloxP or its mutant recognition
site, Vlox2272. These results will stimulate a variety of
applications for using various mutant VloxP sites, appli-
cations that are analogous to those implementing Cre/
mutant loxP such as RMCE methods and inversion of
DNA cassettes. We also identiﬁed lox66/lox71-type
mutant sites (20), Vlox43R/Vlox43L, for inversion and
integration (Supplementary Figure S2).
SCre speciﬁcally recombines the SloxP site
Using the same strategy, we identiﬁed a second recombin-
ase, which we named SCre recombinase (Supplementary
Figures S3 and S4), and its recognition site, SloxP
(Figure 1A), from the 279-kbp sequence of plasmid 1 of
Shewanella sp. ANA-3. We constructed a tester plasmid
by replacing the two VloxP sites of pVloxP-EGFP with
two SloxP sites, and then introduced it into HEK293 cells
lacking and HEK293 cells containing an expression
plasmid expressing SCre recombinase. DNA puriﬁed
from the co-transfected cells was then electroporated into
E. coli to recover the tester plasmid. The tester plasmid
recovered from cells co-transfected with the expression
plasmid expressing SCre was  1 kbp shorter than the
original tester plasmid recovered from cells lacking the ex-
pression plasmid (Figure 1H). DNA sequencing of the
shortened plasmid conﬁrmed that SCre recombinase had
eliminated the 787bp of the blasticidin resistance cassette
ﬂanked by two SloxP sites, demonstrating that SCre can
recombine SloxP.
VCre/VloxP, SCre/SloxP and Cre/loxP do not
cross-react with each other
To conﬁrm that SCre, VCre and Cre do not cross-react,
we transfected tester plasmids containing two SloxP,
loxP or VloxP sites into cells lacking or containing the
expression plasmid expressing SCre recombinase. Site-
speciﬁc recombination was assessed by subjecting DNA
puriﬁed from the transfected cells to PCR analysis. All
of the original tester plasmids produced 2007-bp PCR
products; however, the tester plasmid recombined via
SloxP produced a shorter 1220-bp PCR product
(Figure 1I, lanes SloxP/- and SloxP/SCre). The 787-bp
PCR product representing the blasticidin resistance
cassette ﬂanked by two SloxP sites was eliminated by
SCre recombinase. These results indicate that SCre recom-
binase does not recombine loxP and VloxP (Figure 1I,
lanes loxP/SCre and VloxP/SCre). When a tester
plasmid containing two SloxP sites was transfected into
HEK293 cells containing an expression plasmid express-
ing either Cre or VCre recombinase, no shortened PCR
product was detected (Figure 1I, lanes SloxP/Cre and
SloxP/VCre), indicating that both Cre and VCre also
failed to recombine SloxP.
SloxP and mutant Slox2272 do not cross-react even
though SCre recombines both sites
In addition to mutant VloxP (Vlox2272), we also
designed a mutant SloxP, called Slox2272, which
contains two base substitutions (a C-to-G substitution at
position no. 2 and an A-to-T substitution at position
no. 7) in the 8-bp core sequence of SloxP. We named
this mutant Slox2272 because its base substitutions were
analogous to those of lox2272 and because two other sub-
stitutions in the 8-bp core sequence of Slox2272 matched
that of lox2272 and Vlox2272 (Figure 1A). To conﬁrm the
speciﬁcity of mutant Slox2272, we constructed a tester
plasmid containing two SloxP and two Slox2272 sites
(Figure 1J) and co-transfected it into HEK293 cells
along with a plasmid-lacking recombinase or a plasmid-
expressing-SCre recombinase. We then performed PCR
analyses using primers F and R (Figure 1J) to detect
site-speciﬁc recombination. When the tester plasmid was
introduced into cells lacking recombinase, we detected a
3557-bp PCR product. Its large size indicates that none of
its components were removed by site-speciﬁc recombin-
ation. However in cells expressing SCre recombinase, we
detected a shorter 1661-bp PCR product (Figure 1K, lane
2), which is consistent with a product lacking both the
blasticidin resistance cassette ﬂanked by two SloxP sites
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sites. In addition, two other minor PCR products, 2270
and 2448bp were detected. The 2270-bp PCR product
corresponded to a segment that lacked the blasticidin re-
sistance cassette ﬂanked by two SloxP sites, whereas the
2448-bp PCR product corresponded to a segment that
lacked the Cm resistance cassette ﬂanked by two
Slox2272 sites. The 2270- and 2448-bp PCR products
resulted from the reaction of only one SloxP site or only
one Slox2272 site, respectively, and are thought to be
intermediate products of the reaction producing the ﬁnal
1661-bp product, i.e. reaction of two SloxP sites and two
Slox2272 sites. Since our assay did not detect any other
shortened PCR products, we concluded that SCre reacted
with two Slox2272 sites but did not react to the combin-
ation SloxP/Slox2272 sites (Figure 1K).
To conﬁrm the speciﬁcity of SloxP and Slox2272, we
puriﬁed DNA from the co-transfected cells and
electroporated the DNA into E. coli to recover the tester
plasmid. The tester plasmids recovered from cells
co-transfected with the expression plasmid expressing
SCre were  1.9 kbp shorter than the original tester
plasmid from cells lacking SCre (Figure 1L, lanes 1–4).
DNA sequencing of the shortened plasmids conﬁrmed
that the blasticidin resistance cassette ﬂanked by two
SloxP sites and the Cm resistance cassette ﬂanked by
two Slox2272 sites were eliminated by SCre recombinase.
This conclusively conﬁrmed that SCre reacted speciﬁcally
with SloxP and mutant Slox2272. We also identiﬁed
lox66/lox71-type mutant sites, SloxV1R/SloxV1L, for in-
version and integration (Supplementary Figure S5).
Comparison of the site-speciﬁc recombination efﬁciencies
of VCre and SCre with those of two other recombinases
Next, we compared the efﬁciency of site-speciﬁc recombin-
ation of VCre with that of Cre by ﬁrst constructing ex-
pression plasmids expressing either VCre or Cre in E. coli.
Production of each recombinase was driven by a
temperature-shift inducible promoter. The tester plasmid
contained an Amp resistance cassette ﬂanked by two
VloxP sites and a Cm resistance cassette ﬂanked by two
loxP sites (Figure 2A). The negative control was the empty
vector containing the plasmid backbone, which does not
express recombinase. After electroporation of the tester
plasmid containing two VloxP and two loxP sites into
E. coli DH10B cells that lacked recombinase or expressed
either VCre or Cre, we selected Km-resistant colonies,
which were then replicated on Amp, Cm or Km agar
plates to test their ability to grow. When VCre recombin-
ase recombines the tester plasmid and the Amp resistance
cassette ﬂanked by two VloxP sites is removed,
transformants lose their ability to grow on LB plates con-
taining Amp. Similarly, when Cre recombinase recom-
bines the Cm resistance cassette ﬂanked by two loxP
sites, transformants lose their ability to grow on LB
plates containing Cm. The number of Amp-sensitive
transformants and Cm-sensitive transformants reﬂect the
site-speciﬁc recombination efﬁciencies of VCre and Cre,
respectively. In our system, the recombination efﬁciency
of VCre was almost the same as that of Cre (Figure 2B).
Again, no cross-reactivity of site-speciﬁc recombination
was detected in this assay in E. coli.
We also compared the efﬁciency and speciﬁcity of
site-speciﬁc recombination of VCre, SCre, Cre and Dre
recombinases using the same assay strategy in E. coli.
Tester plasmids were constructed by replacing the two
VloxP sites of a tester plasmid containing the Amp resist-
ance gene with either two SloxM1 sites (for SCre) or two
rox sites (for Dre) (Figure 2A). SloxP is composed of an
8-bp sequence ﬂanked on either side by 13-bp inverted
repeats. Unlike loxP, the two 13-bp segments of SloxP
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Figure 2. Site-speciﬁc recombination of VCre or SCre recombinase in
E. coli. (A) Illustrations of plasmids expressing VCre or SCre recom-
binase under the control of temperature-shift and tester plasmids for
site-speciﬁc recombination. (B) Efﬁciency and speciﬁcity of site-speciﬁc
recombination of VCre and Cre recombinase. After electroporation of
the tester plasmid (A) into E. coli DH10B cells that express either VCre
or Cre, we selected Km-resistant colonies, which were then replicated
on Amp, Cm or Km agar plates to test their ability to grow. The empty
vector contains a backbone plasmid that does not express recombinase.
(C) Efﬁciency and speciﬁcity of site-speciﬁc recombination of VCre,
SCre, Cre and Dre recombinases. The efﬁciency and speciﬁcity of
four recombinases were examined in E. coli. In experiments testing
various pairs of VCre, SCre, Cre and Dre with VloxP, SloxM1, loxP
and rox, we detected no cross-reactivity. The recombination efﬁciencies
of VCre and SCre were almost the same as those of Cre and Dre in an
E. coli site-speciﬁc recombination assay.
e49 Nucleic Acids Research, 2011,Vol. 39,No. 8 PAGE 8 OF 11Figure 3. Genome engineering using mouse ES cells. (A) C-terminal protein-tag exchange in ES cells using the RMCE method. (B) Mouse ES cells
expressing Lin28 with an EGFP tag fused at its C terminus. The EGFP tag was replaced with a DsRed tag. Fluorescence microscopy images showing
the intracellular distribution of Lin28-EGFP (b, e) and Lin28-DsRed (c, f). The corresponding differential interference microscopy images are shown
in (a, d). Scale bar, 10mm. (C) Schematic diagram of genetically modiﬁed alleles of Lin28. The dashed lines indicate the location of the targeting
vectors. (D) PCR analysis of mouse ES cell genome engineered using VCre. The arrow indicates the PCR products in which VloxP-ﬂanked exon 3
was eliminated from ES cells producing VCre. Lanes 1–6 show independently isolated ES colonies after the introduction of VCre. (E)
Southern-hybridization analysis of mouse ES cell genome engineered using VCre. The arrows indicate VloxP-eliminated DNA fragments (5.5 or
4.8 kbp, respectively) in StuI- or EcoRV-digested genomic DNA from ES cells producing VCre. The 1.1-kbp DNA fragment containing exon
3-ﬂanked VloxP was eliminated. (F) Immunoblot analysis of conditional knockout ES-cell genome engineered using the VCre/VloxP system. Only
EGFP-tagged lin28 was detected in the VCre-mediated conditional knockout ES cells. Blots were probed with anti-lin28 antibody. The solid arrow
indicates intact VCre protein; the open arrow indicates Lin28-fused EGFP.
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SloxM1 (CTCGTGTCCGATA ACTGTAAT TATCGG
ACACGAG) was modiﬁed so that the two 13-bp
segments would match perfectly but would not contain
an ATG, which can be used as an initial Met codon.
The recombination efﬁciencies of VCre and SCre were
almost the same as those of Cre and Dre in an E. coli
site-speciﬁc recombination assay (Figure 2C) [a t-test on
the numbers of recombinant cells (three experiments; P >
0.05) produced by these two methods revealed no statis-
tically signiﬁcant differences]. It should be noted that the
codon-usage pattern of VCre and SCre were changed to
match that found in mouse and human. The codon-usage
pattern of Cre and Dre, however, was the original
phage-type pattern, which is suitable for E. coli. In experi-
ments testing various pairs of VCre, SCre, Cre and Dre
with VloxP, SloxM1, loxP and rox, we observed no
cross-reactivity when testing various heterotypic combin-
ations of recombinases and recognition sites (Figure 2C).
Taken together, these ﬁndings show that VCre/VloxP and
SCre/SloxP are sufﬁcient biotechnology tools, because of
their recombination efﬁciency and because VCre and SCre
lack cross-reactivity.
Genome engineering of mouse ES cells: modiﬁcation of
one allele by VCre/VloxP and another allele by Cre/loxP
To test the feasibility and utility of VCre/VloxP to modify
a gene (in this case Lin28) within a genome, we performed
genome engineering on mouse ES cells using VCre/VloxP,
which can genetically modify both alleles of a single
gene. We demonstrated that one allele was modiﬁed by
Cre/loxP and another allele was modiﬁed by VCre/
VloxP. Figure 3A and C depicts the strategy we used to
generate two novel Lin28 (also known as Lin28a) alleles.
First, we performed a knock-in affecting one Lin28 allele,
which could be freely exchanged with a C-terminal protein
tag by using the RMCE method and loxP and lox2272. If
necessary, one can remove the positive antibiotics selec-
tion cassette via the Flp/FRT system in order to enable
reliable Lin28 gene expression. The EGFP C-terminus tag
of lin28 can be exchanged with a DsRed-dependent tag
following RMCE of Cre (see Figure 3B, panels b and f).
Second, we performed a conditional knockout of the other
Lin28 allele (Figure 3C). In this scenario, exon 3 of Lin28
was ﬂanked by two VloxP sites, allowing the deletion of
the gene of interest in a VCre-dependent manner. ES cells
were then genetically modiﬁed by homologous recombin-
ation by introducing the conditional knockout of this par-
ticular Lin28 allele.
We then performed PCR ampliﬁcation analysis using
primers F and R (Figure 3C) on DNA from ES cells har-
boring the two modiﬁed alleles. In the absence of VCre
recombinase, a 3148-bp PCR product was detected.
However, in ES cells transfected with an expression
plasmid expressing VCre recombinase, a 2059-bp PCR
product was detected (Figure 3D). The shorter 2059-bp
PCR product resulted from the removal of the 1089-bp
segment containing exon 3 of Lin28 ﬂanked by two VloxP
sites. Southern hybridization was also performed on StuI-
or EcoRV-digested DNA puriﬁed from ES cells that
lacked or expressed VCre recombinase. The probe
shown in Figure 3C distinguished the two LIN alleles:
the Lin28-EGFP allele and the Lin28 conditional KO
allele. In DNA samples digested with either StuI or
EcoRV, Southern hybridization detected bands from
samples of cells expressing VCre that were 1.1 kbp
shorter than bands from samples of cells lacking VCre:
5.5 versus 6.6 kbp and 4.8 versus 5.9 kbp, respectively
(Figure 3E). This result demonstrated that the removal
of the 1089-bp segment containing exon 3 of Lin28
ﬂanked by two VloxP sites was dependent on VCre ex-
pression. Conclusively, PCR ampliﬁcation and Southern
hybridization veriﬁed the site-speciﬁc recombination of
VCre/VloxP, and direct sequencing analysis of the PCR
products also conﬁrmed recombination with VloxP sites in
the mouse ES cell genome (data not shown).
Finally, we conﬁrmed the expression of lin28.
Immunoblotting analysis revealed two bands representing
intact lin28 and EGFP-tagged lin28, which were detected
before applying VCre (Figure 3F). However, only
EGFP-tagged lin28 was detected after applying VCre.
Intact lin28 in cells harboring the conditional knockout
allele was completely abolished. If necessary, both puro-
mycin and neomycin resistance cassettes can be removed
by using the Flp/FRT system (data not shown). In this
study, we did not detect in our experiments cytotoxicity
toward mouse ES cells, HEK293 cells or E. coli producing
VCre or SCre. According to an in silico search, mouse and
human genomes do not contain identical or sequences
highly similar to VloxP and SloxP.
In the present study, we developed two novel site-
speciﬁc recombination systems: VCre/VloxP and SCre/
SloxP. VCre/VloxP and SCre/SloxP in combination with
both Cre/loxP and Flp/FRT will serve as powerful tools
for genome engineering, especially for applications
requiring the genetic modiﬁcation of both alleles of a
gene of interest in mouse or human cells containing iPS
cells. In this article, we also proposed various potential
applications of the VCre/VloxP and SCre/SloxP systems,
such as double and triple conditional knockouts, condi-
tional knockout with virus vectors containing a Cre/loxP
viral packaging system, and construction of complex
BAC clones (see Supplementary Figures S6–S10). The
VCre/VloxP and SCre/SloxP systems will strongly
motivate novel ideas for genome engineering and BAC
engineering.
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ACKNOWLEDGEMENTS
We are grateful to S. Minorikawa, M. Takayama,
K. Toyama and E. Abe for their excellent technical assist-
ance. We also thank Dr Osamu Ohara for his
encouragement.
e49 Nucleic Acids Research, 2011,Vol. 39,No. 8 PAGE 10 OF 11FUNDING
Grants-in-Aid for Scientiﬁc Research (KAKENHI) from
the Japan Society for the Promotion of Science (JSPS);
grants from the Kazusa DNA Research Institute.
Funding for open access charge: Grants-in-Aid for
Scientiﬁc Research (KAKENHI) from the Japan Society
for the Promotion of Science (JSPS).
Conﬂict of interest statement. None declared.
Note added in proof
The VloxP in this paper is different from loxP V
(shortened name of loxP 2272) appeared in Kondo et al.
Nucleic Acids Res. 31:e76, 2003 and Nakano et al. Nucleic
acids Res. 33:e76, 2005.
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